Nadine Lübke
- Virology top 5%
- HIV Research and Treatment 13
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 18
- SARS-CoV-2 and COVID-19 Research 9
- HIV/AIDS Research and Interventions 8
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 detection and testing 5
- Hepatology top 10%
- Hepatitis C virus research 12
- Animal Science and Zoology top 10%
-
- Hepatitis B Virus Studies 10
Nadine Lübke
41 papers receiving 425 citations
Peers
Comparison fields: 5 of 60
- Virology 104
- Infectious Diseases 305
- Hepatology 54
- Animal Science and Zoology 44
- Epidemiology 113
Countries citing papers authored by Nadine Lübke
This map shows the geographic impact of Nadine Lübke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Lübke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Lübke more than expected).
Fields of papers citing papers by Nadine Lübke
This network shows the impact of papers produced by Nadine Lübke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Lübke. The network helps show where Nadine Lübke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nadine Lübke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 0 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 31 | |
| 12 | 2019 | 5 | |
| 13 | 2018 | 3 | |
| 14 | 2017 | 14 | |
| 15 | 2017 | 10 | |
| 16 | 2016 | 5 | |
| 17 | 2015 | 12 | |
| 18 | 2013 | 12 | |
| 19 | 2011 | 11 | |
| 20 | 2011 | 14 |
About Nadine Lübke
Nadine Lübke is a scholar working on Virology, Infectious Diseases, Hepatology, General Dentistry and Epidemiology, having authored 46 papers that have together received 432 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (13 papers), Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers), HIV/AIDS Research and Interventions (8 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 detection and testing (5 papers). The work is most often cited by research in Virology (104 citations), Infectious Diseases (305 citations), Hepatology (54 citations), Animal Science and Zoology (44 citations) and Epidemiology (113 citations). Nadine Lübke has collaborated with scholars based in Germany, Italy and Slovakia. Frequent co-authors include Rolf Kaiser, Jörg Timm, Andreas Walker, Veronica Di Cristanziano, Marcel Andrée, Ortwin Adams, Sandra Hauka, Tina Senff, Elena Knops and Björn‐Erik Ole Jensen. Their work appears in journals such as Infection, Journal of Clinical Virology, Medical Microbiology and Immunology, JAIDS Journal of Acquired Immune Deficiency Syndromes and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.